European Biotech Acquisit... (EBACU)
NASDAQ: EBACU
· Real-Time Price · USD
11.30
0.40 (3.67%)
At close: Mar 02, 2023, 9:53 PM
European Biotech Acquisition Revenue
European Biotech Acquisition reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2022, European Biotech Acquisition generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
n/a
Employees
n/a
Market Cap
181.22M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2022 | 0 | n/a |
Dec 31, 2021 | 0 | n/a |